Sino Biopharmaceutical Limited (OTCMKTS:SBMFF – Get Free Report)’s stock price hit a new 52-week low during trading on Friday . The company traded as low as $0.32 and last traded at $0.32, with a volume of 500 shares. The stock had previously closed at $0.35.
Sino Biopharmaceutical Trading Down 9.8 %
The company’s 50-day moving average price is $0.36 and its two-hundred day moving average price is $0.39.
About Sino Biopharmaceutical
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines comprising Qingkeshu tablets, Focus V capsules, Annike injection, and Anyue capsules; liver disease medicines, including Tianqing ganmei injection and Runzhong dispersible tablets; and respiratory system medicines, such as Tianqing suchang suspension for inhalation and Tianyun for injection.
Featured Stories
- Five stocks we like better than Sino Biopharmaceutical
- 3 Warren Buffett Stocks to Buy Now
- Comprehensive Analysis of PayPal Stock
- What is a Secondary Public Offering? What Investors Need to Know
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- Most Volatile Stocks, What Investors Need to Know
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Sino Biopharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sino Biopharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.